A mitochondrial component of neurodegeneration in multiple sclerosis (Q35166746)

6 August 2017

1 reference

title

A mitochondrial component of neurodegeneration in multiple sclerosis (English)

1 reference

6 August 2017

0 references

1 reference

Bernadette Kalman

1 reference

6 August 2017

Thomas P Leist

series ordinal

1 reference

6 August 2017

publication date

1 January 2003

1 reference

6 August 2017

published in

NeuroMolecular Medicine

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

page(s)

147-158

1 reference

Oxidative damage to DNA in plaques of MS brains

6 August 2017

cites work

1 reference

12 December 2020

A full genome search in multiple sclerosis

1 reference

12 December 2020

Enhancing magnetic resonance imaging lesions and cerebral atrophy in patients with relapsing multiple sclerosis

1 reference

12 December 2020

Human mitochondrial complex I in health and disease

1 reference

12 December 2020

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

12 December 2020

Parent-child concordance in multiple sclerosis

1 reference

12 December 2020

MR imaging in acute multiple sclerosis: ringlike appearance in plaques suggesting the presence of paramagnetic free radicals

1 reference

12 December 2020

Differential mechanisms of action of interferon-beta and glatiramer aetate in MS.

1 reference

12 December 2020

Oligodendrocytes in the early course of multiple sclerosis

1 reference

12 December 2020

Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis

1 reference

12 December 2020

Serial magnetization transfer imaging to characterize the early evolution of new MS lesions

1 reference

12 December 2020

N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction

1 reference

12 December 2020

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group

1 reference

12 December 2020

Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences

1 reference

12 December 2020

Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11778 or 14484 mutations on an mtDNA lineage.

1 reference

12 December 2020

Mitochondrial DNA mutations in multiple sclerosis patients with severe optic involvement

1 reference

12 December 2020

The activation of protein kinase C induces higher production of reactive oxygen species by mononuclear cells in patients with multiple sclerosis than in controls

1 reference

12 December 2020

Role of Fas--FasL interactions in the pathogenesis and regulation of autoimmune demyelinating disease

1 reference

12 December 2020

Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis

1 reference

12 December 2020

Mitochondrial respiratory chain disorders I: mitochondrial DNA defects

1 reference

12 December 2020

Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects

1 reference

12 December 2020

Characterization of the mitochondrial DNA in patients with multiple sclerosis

1 reference

12 December 2020

Breaking the mitochondrial barrier

1 reference

12 December 2020

Mechanisms of damage to myelin and oligodendrocytes and their relevance to disease

1 reference

12 December 2020

Sequence variation in the transforming growth factor-beta1 (TGFB1) gene and multiple sclerosis susceptibility

1 reference

12 December 2020

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

12 December 2020

LEBER'S DISEASE WITH SYMPTOMS RESEMBLING DISSEMINATED SCLEROSIS

1 reference

12 December 2020

Association of the 11778 mitochondrial DNA mutation and demyelinating disease

1 reference

12 December 2020

Relapses and progression of disability in multiple sclerosis

1 reference

12 December 2020

Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis

1 reference

12 December 2020

Mitochondrial DNA mutations in multiple sclerosis

1 reference

12 December 2020

Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis

1 reference

12 December 2020

A meta-analysis of genomic screens in multiple sclerosis. The Transatlantic Multiple Sclerosis Genetics Cooperative

1 reference

12 December 2020

Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation

1 reference

12 December 2020

A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22

1 reference

12 December 2020

Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases

1 reference

12 December 2020

Genomewide Scan of Multiple Sclerosis in Finnish Multiplex Families

1 reference

12 December 2020

Apoptosis of inflammatory cells in immune control of the nervous system: role of glia

1 reference

12 December 2020

Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis

1 reference

12 December 2020

Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS

1 reference

12 December 2020

Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology

1 reference

12 December 2020

Pathogenesis of tissue injury in MS lesions

1 reference

12 December 2020

A putative vulnerability locus to multiple sclerosis maps to 5p14-p12 in a region syntenic to the murine locus Eae2

1 reference

12 December 2020

Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis

1 reference

12 December 2020

Linkage and association analysis of susceptibility regions on chromosomes 5 and 6 in 106 Scandinavian sibling pair families with multiple sclerosis

1 reference

12 December 2020

Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis

1 reference

12 December 2020

No association of the 11778 mitochondrial DNA mutation and multiple sclerosis in Japan

1 reference

12 December 2020

Patterns of oligodendroglia pathology in multiple sclerosis

1 reference

12 December 2020

Axonal transection in the lesions of multiple sclerosis

1 reference

12 December 2020

Large scale screening of the mitochondrial DNA reveals no pathogenic mutations but a haplotype associated with multiple sclerosis in Caucasians

1 reference

12 December 2020

Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis

1 reference

12 December 2020

Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial.

1 reference

12 December 2020

Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation

1 reference

12 December 2020

Screening for Leber's hereditary optic neuropathy associated mitochondrial DNA mutations in patients with prominent optic neuritis

1 reference

12 December 2020

CD95 expression and CD95-mediated apoptosis of T cells in multiple sclerosis. No differences from normal individuals and no relation to HLA-DR2.

1 reference

12 December 2020

Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis

1 reference

12 December 2020

Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice

1 reference

12 December 2020

Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group

1 reference

12 December 2020

A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group

1 reference

12 December 2020

Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Chemical pathology of acute demyelinating lesions and its correlation with disability

1 reference

12 December 2020

The mitochondrion in apoptosis: how Pandora's box opens

1 reference

12 December 2020

Leber's hereditary optic neuropathy mitochondrial DNA mutations in childhood multiple sclerosis

1 reference

12 December 2020

Identifiers

DOI

10.1385/NMM:3:3:147

1 reference

Dimensions Publication ID

6 August 2017

1019333432

0 references

Fatcat ID

release_plt6pifr4jbp3frdffjugpw3gu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/plt6pifr4jbp3frdffjugpw3gu

24 November 2022

mapped directly with Wikidata item

1 reference